Jeremy D. Baker

1.5k total citations
24 papers, 846 citations indexed

About

Jeremy D. Baker is a scholar working on Molecular Biology, Physiology and Cell Biology. According to data from OpenAlex, Jeremy D. Baker has authored 24 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 7 papers in Physiology and 4 papers in Cell Biology. Recurrent topics in Jeremy D. Baker's work include Heat shock proteins research (9 papers), Signaling Pathways in Disease (6 papers) and Alzheimer's disease research and treatments (4 papers). Jeremy D. Baker is often cited by papers focused on Heat shock proteins research (9 papers), Signaling Pathways in Disease (6 papers) and Alzheimer's disease research and treatments (4 papers). Jeremy D. Baker collaborates with scholars based in United States, Germany and Russia. Jeremy D. Baker's co-authors include Laura J. Blair, Chad A. Dickey, Jonathan J. Sabbagh, April L. Darling, Dali Zheng, Bryce A. Nordhues, Sarah N. Fontaine, Mackenzie D. Martin, Markus Zweckstetter and Brian C. Kraemer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Journal of Clinical Investigation.

In The Last Decade

Jeremy D. Baker

24 papers receiving 835 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeremy D. Baker United States 17 547 275 169 103 72 24 846
April L. Darling United States 19 1.0k 1.9× 252 0.9× 207 1.2× 132 1.3× 49 0.7× 24 1.4k
Zsolt Bozsó Hungary 17 422 0.8× 344 1.3× 81 0.5× 169 1.6× 88 1.2× 35 818
Giulia Vecchi United Kingdom 10 515 0.9× 257 0.9× 182 1.1× 87 0.8× 26 0.4× 11 829
Lingyan Ping United States 13 488 0.9× 428 1.6× 65 0.4× 63 0.6× 40 0.6× 26 870
Adriano Sebollela Brazil 16 355 0.6× 390 1.4× 87 0.5× 190 1.8× 104 1.4× 28 779
Anna L. Gharibyan Sweden 15 565 1.0× 395 1.4× 44 0.3× 126 1.2× 42 0.6× 24 870
Riikka‐Liisa Uronen Finland 13 562 1.0× 404 1.5× 289 1.7× 159 1.5× 50 0.7× 16 1.0k
Ann‐Christin Brorsson Sweden 14 393 0.7× 448 1.6× 78 0.5× 76 0.7× 129 1.8× 27 697
Xiaojuan Sun China 12 365 0.7× 205 0.7× 109 0.6× 40 0.4× 89 1.2× 25 772
Chuchu Wang United States 13 417 0.8× 178 0.6× 111 0.7× 66 0.6× 17 0.2× 29 775

Countries citing papers authored by Jeremy D. Baker

Since Specialization
Citations

This map shows the geographic impact of Jeremy D. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeremy D. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeremy D. Baker more than expected).

Fields of papers citing papers by Jeremy D. Baker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeremy D. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeremy D. Baker. The network helps show where Jeremy D. Baker may publish in the future.

Co-authorship network of co-authors of Jeremy D. Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Jeremy D. Baker. A scholar is included among the top collaborators of Jeremy D. Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeremy D. Baker. Jeremy D. Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McMillan, Pamela J., Aleen D. Saxton, Timothy J. Strovas, et al.. (2023). Tau–RNA complexes inhibit microtubule polymerization and drive disease-relevant conformation change. Brain. 146(8). 3206–3220. 18 indexed citations
2.
Baker, Jeremy D., et al.. (2021). A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV2 main protease. PLoS ONE. 16(2). e0245962–e0245962. 42 indexed citations
3.
Criado‐Marrero, Marangelie, et al.. (2021). Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice. Acta Neuropathologica Communications. 9(1). 65–65. 33 indexed citations
4.
Ma, Chao, Jerry B. Hunt, Huimin Liang, et al.. (2021). Aberrant AZIN2 and polyamine metabolism precipitates tau neuropathology. Journal of Clinical Investigation. 131(4). 26 indexed citations
5.
Criado‐Marrero, Marangelie, et al.. (2021). Correction to: Hsp90 co‑chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild‑type mice. Acta Neuropathologica Communications. 9(1). 85–85. 3 indexed citations
6.
Baker, Jeremy D., et al.. (2020). AlphaScreen Identifies MSUT2 Inhibitors for Tauopathy-Targeting Therapeutic Discovery. SLAS DISCOVERY. 26(3). 400–409. 2 indexed citations
7.
Favretto, Filippo, David Flores‐Solis, Jeremy D. Baker, et al.. (2020). Catalysis of proline isomerization and molecular chaperone activity in a tug-of-war. Nature Communications. 11(1). 6046–6046. 25 indexed citations
8.
Baker, Jeremy D., et al.. (2020). Targeting Pathological Tau by Small Molecule Inhibition of the Poly(A):MSUT2 RNA–Protein Interaction. ACS Chemical Neuroscience. 11(15). 2277–2285. 20 indexed citations
9.
Ma, Chao, Jerry B. Hunt, April L. Darling, et al.. (2019). Spermidine/spermine-N1-acetyltransferase ablation impacts tauopathy-induced polyamine stress response. Alzheimer s Research & Therapy. 11(1). 58–58. 36 indexed citations
10.
Darling, April L., Leonid Breydo, Dali Zheng, et al.. (2019). Repeated repeat problems: Combinatorial effect of C9orf72-derived dipeptide repeat proteins. International Journal of Biological Macromolecules. 127. 136–145. 11 indexed citations
11.
Favretto, Filippo, Jeremy D. Baker, Timo Strohäker, et al.. (2019). The Molecular Basis of the Interaction of Cyclophilin A with α‐Synuclein. Angewandte Chemie International Edition. 59(14). 5643–5646. 20 indexed citations
12.
Baker, Jeremy D., et al.. (2018). Hsp90 Heterocomplexes Regulate Steroid Hormone Receptors: From Stress Response to Psychiatric Disease. International Journal of Molecular Sciences. 20(1). 79–79. 54 indexed citations
13.
Oroz, Javier, Bliss Chang, Chung‐Tien Lee, et al.. (2018). Structure and pro-toxic mechanism of the human Hsp90/PPIase/Tau complex. Nature Communications. 9(1). 4532–4532. 70 indexed citations
14.
Baker, Jeremy D., Dali Zheng, Filippo Favretto, et al.. (2017). Human cyclophilin 40 unravels neurotoxic amyloids. PLoS Biology. 15(6). e2001336–e2001336. 48 indexed citations
15.
Fontaine, Sarah N., Dali Zheng, Jonathan J. Sabbagh, et al.. (2016). DnaJ/Hsc70 chaperone complexes control the extracellular release of neurodegenerative‐associated proteins. The EMBO Journal. 35(14). 1537–1549. 147 indexed citations
16.
Evans, Anthony J., Terence Tse, & Jeremy D. Baker. (2016). The Great EU Debt Write-Off. Simulation & Gaming. 47(4). 543–556. 1 indexed citations
17.
Fontaine, Sarah N., et al.. (2015). Cellular factors modulating the mechanism of tau protein aggregation. Cellular and Molecular Life Sciences. 72(10). 1863–1879. 49 indexed citations
18.
Blair, Laura J., Jeremy D. Baker, Jonathan J. Sabbagh, & Chad A. Dickey. (2015). The emerging role of peptidyl‐prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's disease. Journal of Neurochemistry. 133(1). 1–13. 84 indexed citations
19.
Baker, Jeremy D., et al.. (2004). Effects of breast augmentation on pectoralis major muscle function in the athletic woman. Aesthetic Surgery Journal. 24(3). 224–228. 13 indexed citations
20.
Baker, Jeremy D., et al.. (1990). The Effectiveness of Small-Group versus One-to-One Remedial Instruction for Six Students with Learning Difficulties. The Elementary School Journal. 91(1). 65–76. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by April L. Darling Breakdown of academic impact, for papers by Zsolt Bozsó Breakdown of academic impact, for papers by Giulia Vecchi Breakdown of academic impact, for papers by Lingyan Ping Breakdown of academic impact, for papers by Adriano Sebollela Breakdown of academic impact, for papers by Anna L. Gharibyan Breakdown of academic impact, for papers by Riikka‐Liisa Uronen Breakdown of academic impact, for papers by Ann‐Christin Brorsson Breakdown of academic impact, for papers by Xiaojuan Sun Breakdown of academic impact, for papers by Chuchu Wang
Rankless by CCL
2026